Cover Image
市場調查報告書

肺炎:全球臨床實驗趨勢

Pneumonia Global Clinical Trials Review, H1, 2015

出版商 GlobalData 商品編碼 229134
出版日期 內容資訊 英文 125 Pages
訂單完成後即時交付
價格
Back to Top
肺炎:全球臨床實驗趨勢 Pneumonia Global Clinical Trials Review, H1, 2015
出版日期: 2015年06月16日 內容資訊: 英文 125 Pages
簡介

本報告提供肺炎臨床實驗相關之最新趨勢分析,提供您各地區的臨床實驗數量,臨床實驗的各階段進展,實驗對像採用狀況,有潛力的贊助商,各企業和研究機關的研究進展,有潛力的藥劑比較等資訊。

簡介

  • 肺炎
  • 本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 亞太地區主要5國的臨床實驗數量
    • 歐洲主要5國的臨床實驗數量
    • 北美主要國家的臨床實驗數量
    • 中東·非洲的主要5個國家臨床實驗數量
    • 中南美的主要5個國家臨床實驗數量

G7各國臨床實驗數量:感染疾病治療藥臨床實驗上肺炎的比例

G7各國的各階段臨床實驗數量

G7各國臨床實驗數量:各進展狀況

E7各國臨床實驗數量:感染疾病治療藥臨床實驗上肺炎的比例

E7各國的各階段臨床實驗數量

E7各國臨床實驗數量:各進展狀況

各階段臨床實驗數量

  • 進行中的臨床實驗:各階段

各進展狀況臨床實驗數量

臨床實驗的目標達成情形

未完成的臨床實驗數量

一定期間所採用的實驗對像

贊助商類別的臨床實驗數量

有潛力的贊助商

肺炎臨床實驗的主要參與企業

有潛力的藥劑

最新臨床實驗新聞

臨床實驗簡介

  • 主要企業臨床實驗概要
    • Pfizer Inc.
    • GlaxoSmithKline Plc
    • AstraZeneca Plc
    • Sanofi
    • Merck & Co., Inc.
    • Actavis plc
    • Johnson & Johnson
    • Bayer AG
    • Forest Laboratories, Inc.
    • Cempra, Inc.
  • 有代表性的研究機關·醫院臨床實驗概要
    • The National Institute of Allergy and Infectious Diseases
    • Medical University of Vienna
    • NEOCI
    • 東北大學
    • Arak University of Medical Sciences
    • Eunice Kennedy Shriver National Institute of Child Health and Human Development
    • Kermanshah University of Medical Sciences
    • National Taiwan University Hospital
    • Ono Municipal Hospital
    • St. Antonius Hospital

5個有代表性的臨床實驗簡介

附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDHC2733CTIDB

GlobalData's clinical trial report, "Pneumonia Global Clinical Trials Review, H1, 2015" provides an overview of Pneumonia clinical trials scenario. This report provides top line data relating to the clinical trials on Pneumonia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Pneumonia
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Five Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Five Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Pneumonia to Infectious Disease Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Pneumonia to Infectious Disease Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Pneumonia
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Pneumonia Therapeutics Clinical Trials
  • Prominent Drugs
    • Latest Clinical Trials News on Pneumonia
      • Mar 26, 2015: Aridis Pharmaceuticals Commences Phase 1 Clinical Study of Aerucin Monoclonal Antibody for Acute Pneumonia
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Pfizer Inc.
      • Clinical Trial Overview of Pfizer Inc.
      • GlaxoSmithKline Plc
      • Clinical Trial Overview of GlaxoSmithKline Plc
      • AstraZeneca Plc
      • Clinical Trial Overview of AstraZeneca Plc
      • Sanofi
      • Clinical Trial Overview of Sanofi
      • Merck & Co., Inc.
      • Clinical Trial Overview of Merck & Co., Inc.
      • Actavis plc
      • Clinical Trial Overview of Actavis plc
      • Johnson & Johnson
      • Clinical Trial Overview of Johnson & Johnson
      • Bayer AG
      • Clinical Trial Overview of Bayer AG
      • Forest Laboratories, Inc.
      • Clinical Trial Overview of Forest Laboratories, Inc.
      • Cempra, Inc.
      • Clinical Trial Overview of Cempra, Inc.
    • Clinical Trial Overview of Top Institutes / Government
      • The National Institute of Allergy and Infectious Diseases
      • Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases
      • Medical University of Vienna
      • Clinical Trial Overview of Medical University of Vienna
      • Nagasaki Evaluation Organization for Clinical Interventions
      • Clinical Trial Overview of Nagasaki Evaluation Organization for Clinical Interventions
      • Tohoku University
      • Clinical Trial Overview of Tohoku University
      • Arak University of Medical Sciences
      • Clinical Trial Overview of Arak University of Medical Sciences
      • Eunice Kennedy Shriver National Institute of Child Health and Human Development
      • Clinical Trial Overview of Eunice Kennedy Shriver National Institute of Child Health and Human Development
      • Kermanshah University of Medical Sciences
      • Clinical Trial Overview of Kermanshah University of Medical Sciences
      • National Taiwan University Hospital
      • Clinical Trial Overview of National Taiwan University Hospital
      • Ono Municipal Hospital
      • Clinical Trial Overview of Ono Municipal Hospital
      • St. Antonius Hospital
      • Clinical Trial Overview of St. Antonius Hospital
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Pneumonia Therapeutics, Global, Clinical Trials by Region, 2015*
  • Pneumonia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Pneumonia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Pneumonia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015*
  • Pneumonia Therapeutics Clinical Trials, Europe, Top Five Countries, 2015*
  • Pneumonia Therapeutics Clinical Trials, North America, Top Countries, 2015*
  • Pneumonia Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2015*
  • Pneumonia Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2015*
  • Proportion of Pneumonia to Infectious Disease Clinical Trials, G7 Countries (%), 2015*
  • Pneumonia Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Pneumonia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Pneumonia to Infectious Disease Clinical Trials, E7 Countries (%), 2015*
  • Pneumonia Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Pneumonia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Pneumonia Therapeutics, Global, Clinical Trials by Phase, 2015*
  • Pneumonia Therapeutics, Global, Clinical Trials In Progress by Phase 2015*
  • Pneumonia Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Pneumonia Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Pneumonia Therapeutics, Global, Suspended Clinical Trials, 2015*
  • Pneumonia Therapeutics, Global, Withdrawn Clinical Trials, 2015*
  • Pneumonia Therapeutics, Global, Terminated Clinical Trials, 2015*
  • Pneumonia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Pneumonia Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015*
  • Pneumonia Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Pneumonia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Pneumonia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2015*
  • Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline Plc, 2015*
  • Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca Plc, 2015*
  • Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2015*
  • Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2015*
  • Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Actavis plc, 2015*
  • Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2015*
  • Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2015*
  • Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Forest Laboratories, Inc., 2015*
  • Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Cempra, Inc., 2015*
  • Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2015*
  • Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of Vienna, 2015*
  • Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Nagasaki Evaluation Organization for Clinical Interventions, 2015*
  • Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Tohoku University, 2015*
  • Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Arak University of Medical Sciences, 2015*
  • Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Eunice Kennedy Shriver National Institute of Child Health and Human Development, 2015*
  • Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Kermanshah University of Medical Sciences, 2015*
  • Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by National Taiwan University Hospital, 2015*
  • Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Ono Municipal Hospital, 2015*
  • Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by St. Antonius Hospital, 2015*

List of Figures

  • Pneumonia Therapeutics, Global, Clinical Trials by Region (%), 2015*
  • Pneumonia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Pneumonia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Pneumonia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015*
  • Pneumonia Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015*
  • Pneumonia Therapeutics Clinical Trials, North America, Top Countries (%), 2015*
  • Pneumonia Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2015*
  • Pneumonia Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2015*
  • Proportion of Pneumonia to Infectious Disease Clinical Trials, G7 Countries (%), 2015*
  • Pneumonia Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Pneumonia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Pneumonia to Infectious Disease Clinical Trials, E7 Countries (%), 2015*
  • Pneumonia Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Pneumonia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Pneumonia Therapeutics, Global, Clinical Trials by Phase (%), 2015*
  • Pneumonia Therapeutics, Global, Clinical Trials In Progress by Phase, 2015*
  • Pneumonia Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Pneumonia Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Pneumonia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Pneumonia Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015*
  • Pneumonia Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Pneumonia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Pneumonia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • GlobalData Methodology
Back to Top